Pharma Company And Drug Testing Industry Claim Trump's Rescheduling Move Will 'Increase Marijuana Abuse'
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Pharma Company And Drug Testing Industry Claim Trump's Rescheduling Move Will 'Increase Marijuana Abuse'" is generating significant coverage in the Business category, with 7 articles from 4 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Marijuana Moment, MJBizDaily, Business of Cannabis and The Motley Fool. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 49d ago.
Quick answers
Why is "Pharma Company And Drug Testing Industry Claim Trump's Rescheduling Move Will 'I" trending?
Because 4 independent news sources published 7 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- Federal Marijuana Rescheduling Hearing Wraps Up, With DEA Judge Laying Out Next Steps Marijuana Moment · 52d ago
- Cannabis industry encouraged as DEA marijuana rescheduling hearings conclude MJBizDaily · 52d ago
- DEA Rescheduling Hearing Closes as States' Own Witness Concedes Regulation Reduces Crime Business of Cannabis · 52d ago
- President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray The Motley Fool · 52d ago
- Marijuana Companies Shouldn't Be Allowed To Defend Rescheduling By Joining Lawsuit, Anti-Cannabis Groups Say Marijuana Moment · 52d ago
- What cannabis operators should do after the DEA rescheduling hearings MJBizDaily · 52d ago
- Pharma Company And Drug Testing Industry Claim Trump's Rescheduling Move Will 'Increase Marijuana Abuse' Marijuana Moment · 52d ago
Topics
Related trends
Novartis’s Latest Trial Setback Sinks Stock
Novartis shares drop significantly following multiple trial setbacks and difficult dealmaking in the pharmaceutical sector.
Star Wars Zero Company Review: Good Characters & Combat But Janky Camera
Star Wars Zero Company debuts with strong characters and combat paired with a janky camera, according to early reviews.
Nike Stock Fell 78% And S&P 100 Exit May Mark Capitulation
Nike stock hit a 12-year low and the company was removed from the S&P 100 after an 18-year run.
A ‘monster web’ of ocean currents is set to collapse. And the US is not prepared
Scientific research suggests a 'monster web' of Atlantic ocean currents is facing potential collapse, leaving the US unprepared for the resulting climate shifts.
Another Heart Drug Fails, Shocking Cardiologists
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Apple Is Testing a Four-HomePod Surround System, Code Suggests
5 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.